PJP

PowerShares Dynamic Pharmaceuticals Portfolio
A

47
  • Overview
  • Efficiency
  • Tradability
  • Fit

PJP Fund Description

The PowerShares Dynamic Pharmaceuticals Portfolio ETF tracks an index of US pharmaceutical companies selected and weighted based on various fundamental and risk factors.

PJP Factset Analytics Insight

PJP uses a quant-driven methodology to select and weight pharmaceutical companies based on fundamental and risk factors. Although some of the major names are represented in the portfolio, PJP’s multifactor selection process tilts the fund toward mid and small-caps resulting in a low overall weighted average market cap, typically about half of our industry benchmark. Still, its small portfolio takes concentrated stakes in some leading names. Despite a hefty expense ratio and poor tracking in comparison to peers, PJP has attracted sizable AUM and trades easily at decent spreads.

PJP MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of November 21, 2017 the PowerShares Dynamic Pharmaceuticals Portfolio MSCI ESG Fund Quality Score is 4.35 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. PJP ranks in the 15th percentile within its peer group and in the 15th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

PJP Top 10 Countries

PJP Top 10 Sectors

PJP Top 10 Holdings View All

PJP Summary Data

PowerShares
06/23/05
Open-Ended Fund
0.57%
$643.2M
$3.34M
0.07%

PJP Portfolio Data

$75.85B
-17.11
3.76
0.84%
12/15/17
30

PJP Index Data

Tiered
Multi-Factor
Thomson Reuters US Pharmaceuticals

Related ETFs to PJP

FTXH, IHE, XPH
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

PJP Portfolio Management

0.57%
-0.44%
-0.35%
-0.57%

PJP Tax Exposures

20% / 39.6%
--
Qualified dividends
No

PJP Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
09:39:4762.61100
09:34:2162.51450
09:34:2162.51100
09:34:2162.52100
------
------
------
------
------
------
Bats BZX Real-time Quote - 13:09:19
Daily Spread
Premium/Discount
Volume

PJP Factset Analytics Block Liquidity

As of 11/22/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PJP. PJP is rated a 5 out of 5.

PJP Tradability

52,020
$3.34M
42,714
$2.77M
0.07%
$0.05
-0.04%
0.08% / -0.12%
None
100%
50,000
0.85
0.02%
0.31%
488
$62.32
5

PJP Sector/Industry BreakdownView All

PJPSegment Benchmark
86.27% 70.90%

PJP Geographic Exposure

PJPSegment Benchmark
100.00% 100.00%

PJPSegment Benchmark
100.00% 100.00%
0.00% / 0.00% 0.00% / 0.00%

PJP Performance Statistics

0.59
1.13
1.11
1.19
0.55%
Thomson Reuters US Pharmaceuticals

PJP MSCI ESG Ratings

4.35 / 10
14.53
15.17
--
25.01%
30.78

PJP BENCHMARK COMPARISON

    PJP
    30 Holdings
    Segment Benchmark
    50 Constituents
    Shared Holdings
    24 (Count)
     
    47.55% (Weight)
PJPSegment Benchmark
174.77 B 75.85 B
96.39% 53.48%
2.12% 15.38%
1.33% 31.13%
0.17% 0.00%
28.28 -17.11
2.13% 1.05%
High Medium